LABORATORY CORPORATION OF AMERICA HOLDINGS Funds and ETFs Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207.9 USD | -0.01% |
|
+3.99% | -8.51% |
ETFs positioned on Laboratory Corporation of America Holdings
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.97% | 2 M€ | +5.19% | ||
| 1.95% | 8 M€ | -.--% | ||
| 0.82% | 18 M€ | +3.11% | - | |
| 0.43% | 10 M€ | +5.63% | ||
| 0.39% | 92 M€ | +0.06% | - | |
| 0.27% | 9 M€ | -.--% | - | |
| 0.23% | 1 M€ | +11.94% | - | |
| 0.23% | 13 M€ | -.--% | - | |
| 0.23% | 3 M€ | +7.32% | - | |
| 0.19% | 5 M€ | -72.95% | - | |
| 0.19% | 52 M€ | +6.40% | ||
| 0.18% | 2 M€ | +20.44% | - | |
| 0.15% | 8 M€ | +3.59% | - | |
| 0.15% | 33 M€ | +0.60% | - | |
| 0.15% | 18 M€ | +3.59% | - | |
| 0.14% | 469 M€ | -2.05% | - | |
| 0.14% | 3,859 M€ | +18.82% | - | |
| 0.12% | 2,510 M€ | +10.64% | ||
| 0.11% | 4,592 M€ | +11.18% | ||
| 0.11% | 1,006 M€ | -.--% | - | |
| 0.11% | 414 M€ | +8.89% | - | |
| 0.11% | 322 M€ | +13.88% | - | |
| 0.11% | 29 M€ | -.--% | - | |
| 0.10% | 219 M€ | +17.17% | - | |
| 0.10% | 1,448 M€ | -.--% | - | |
| 0.10% | 9 M€ | +1.29% | - | |
| 0.10% | 736 M€ | +6.53% | ||
| 0.09% | 330 M€ | -.--% | - |
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows:
- clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services;
- development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies.
Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
2024-04-24
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
207.9
USD
Average target price
243.8
USD
Spread / Average Target
+17.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.51% | 17.5B | |
| -14.17% | 86.34B | |
| +17.86% | 84.49B | |
| +10.92% | 29.68B | |
| -2.67% | 16.67B | |
| -0.24% | 15.18B | |
| -3.63% | 12.71B | |
| +2.63% | 12.53B | |
| -30.53% | 11.89B | |
| +26.71% | 11.74B |
- Stock Market
- Equities
- LH Stock
- Funds and ETFs Laboratory Corporation of America Holdings
